Brief: MedinCell: Mdc-CWM Clinical Phase 3 Will Start In 2021

Medincell SA

25/03/2021 16:53

March 25 (Reuters) - MEDINCELL SA  MEDCL.PA :
    * MDC-CWM CLINICAL PHASE 3 WILL START IN 2021
    * AN OPEN LABEL SAFETY STUDY TO SUPPLEMENT MDC-CWM LONG-TERM
SAFETY DATABASE WILL START IN Q2 2021
    * NEXT STAGE IN DEVELOPMENT IS PLANNED TO START IN Q2 2021
WITH
INITIATION OF AN OPEN LABEL SAFETY STUDY TO SUPPLEMENT MDC-CWM
LONG-TERM SAFETY DATABASE

Source text for Eikon:  ID:nBw4PYFTva 
Further company coverage:  MEDCL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))